Brendan Swain, PhD, is currently serving as the Chief Scientific Officer at Shift Bioscience, a position held since March 2021. Prior to this role, Brendan completed a Doctor of Philosophy in Pharmacology at the University of Cambridge from 2016 to 2020, following an undergraduate degree in Natural Sciences with a focus on Pharmacology at the same institution from 2013 to 2016. Brendan's academic journey began at Dame Alice Owen's School, where studies were completed from 2006 to 2013.